Search
Dyne Therapeutics Inc
DYNAdd to Watchlist
19.800USD
+0.600+3.13%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.27BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
16
analysts
Buy
Current Rating
39.600
Target Price
+106.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Dyne Therapeutics Inc
DYN
16
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Dyne Therapeutics Inc's price target?
Analysts forecast that Dyne Therapeutics Inc's price target is USD 36.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 9.00.
How have Dyne Therapeutics IncDYN's recent earnings per share performed?
The market expectation was USD -0.73, while Dyne Therapeutics IncDYN's earnings per share (EPS) for the previous quarter was USD -0.75. EPS for the next quarter is expected at USD -0.75.
What is the analyst rating for Dyne Therapeutics Inc?
Based on the ratings of Dyne Therapeutics Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
